Posts from ‘March, 2009’

PARSIPPANY, N.J., March 26 (HSMN NewsFeed) — Custom Spine announced today that Frank Herrington has been named Vice President of Revenue for the Southeast region. Frank brings with him over 27 years of experience in the orthopedic and pharmaceutical device marke…
Devices, Orthopaedic, Personnel
Custom Spine

Decision Represents First Step in Orderly Exit from the Diabetes Business Over Time ST. PAUL, Minn.–(HSMN NewsFeed)–Smiths Pharma announced today its intent to stop selling the Deltec Cozmo(R) insulin pump, and manage an orderly, carefully controlled…
Devices, Endocrinology
Smiths Clinical, Deltec Cozmo, insulin pump, diabetes

SEATTLE–(HSMN NewsFeed)–Calypso(R) Clinical Technologies, Inc., a pharmaceutical device company dedicated to shaping the future of radiation therapy delivery and management, today announced that First Coast Service Options, the Medicare Administrative Contractor…
Devices, Oncology, Reimbursement
Calypso Clinical Technologies, 4D Localization System, radiotherapy

SALT LAKE CITY, UT–Mar 24, 2009 — Myriad Genetics, Inc. (NasdaqGS:MYGN ) announced today its support of The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin Number 103, dated April 2009, which sets forth ACOG’s clinical manage…
Diagnostics, Oncology
Myriad Genetics, ACOG , BRCA1, BRCA2, BRACAnalysis

Indication Offers New Option for Adult Patients Suffering From Community-Acquired Bacterial Pneumonia COLLEGEVILLE, Pa., March 24 (HSMN NewsFeed) — Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announced today that the U.S. Food and Drug A…
Biopharmaceuticals, FDA
Wyeth, TYGACIL, tigecycline, community-acquired bacterial pneumonia

MURRIETA, CA–Mar 24, 2009 — CLX Medical, Inc. (Other OTC:CLXM.PK ), which is focused on the product management and distribution of unique medical diagnostic testing products, today announced the resignation of CEO Vera Leonard, effective March 16, 2009. "…
Diagnostics, Personnel
CLX Clinical

SAN DIEGO, March 23 (HSMN NewsFeed) — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today it has obtained an equity financing commitment of up to $50 million from Azimuth Opportunity Ltd. During the 18-month term of the equity financing commitme…
Biopharmaceuticals, Venture Capital
Arena Pharmaceuticals

CHADDS FORD, Pa., March 23 (HSMN NewsFeed) — Endo Pharmaceuticals (Nasdaq: ENDP ) today announced the successful completion of its acquisition of Indevus Pharmaceuticals, Inc. Endo acquired Indevus through a delicate offer and subsequent merger upon which…
Biopharmaceuticals, Mergers & Acquisitions
Endo Pharmaceuticals, Indevus Pharmaceuticals

Lot Number 112680A, Expiration Date July 31, 2010 CORONA, CA–Mar 23, 2009 — Watson Pharmaceuticals, Inc. (NYSE:WPI ), a leading specialty clinical company, announced today that one lot of Propafenone HCL 225 mg Tablets sold in One hundred count bottles …
Biopharmaceuticals, Generics, Product Recall
Watson Pharmaceuticals, Propafenone

Advanced Wound Care Product Encourages the Body to Heal Wounds With New Tissue Instead of Forming Scar Tissue MUNDELEIN, IL–Mar 23, 2009 — Medline Industries, Inc., today announced the launch of MatriStem Extracellular Matrix Wound Sheet, a new cuttin…
Devices, Wound Care, Distribution
Medline Industries, MatriStem, ACell , Extracellular Matrix, Wound Sheet